AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences’ (UB SPPS) Drug Discovery, Development and Evaluation (DDDE) Hub, a leading research engine in the fields of pharmaceutical ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

Absci Corporation and Owkin have announced a partnership to combine their advanced AI platforms for the rapid discovery and design of novel therapeutics. Absci, known for its generative AI in drug ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.